- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00948207
Online and Narrative Interventions for Advanced Cancer Patients
Online Narrative Interventions and Family Support for Advanced Cancer Patients
The investigators will test whether narrative life review and web-based social networking for middle aged adults with advanced cancer will improve:
- existential well being (and reduce psychological distress)
- generativity and relationship quality, thereby mediating the intervention effects
The investigators will also conduct exploratory process analyses of each participant's social network.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Middle aged patients with advanced cancer report more distress, and active search for meaning and personal growth than older and/or early stage patients. Nonetheless, such positive growth is far from typical and interventions help. Expert-guided life review reduced distress for hospice patients, but is not widely accessible-and many patients lack the energy or skill to write their own life story. Online cancer information and support expert systems improve quality of life. Patients are increasingly developing their own social networks, but many lack the skills to do so. Moreover the effects on social networking on patient well-being have not been studied.
"My Living Story" elicits a dignity-enhancing life story via a telephone interview (based on Chochinov, JAMA 2002), and delivers the edited transcript on the patient's personal miLivingStory social network. miLivingStory links to a life review education website (called miStory) with links to high quality cancer information, support and interactive planning tools.
We hypothesize that telling, revising and sharing the life story with one's selected social network will improve the patient's existential well-being and reduce their distress. Furthermore, we hypothesize that these effects will be mediated by My Living Story's effects on improving the patient's sense of legacy (generativity) and the quality of their relationships. Our exploratory observational analyses of each individual miLivingStory network will contribute to an understanding of how social network configuration and communication patterns correlate with measured outcomes
We will recruit and randomize 100 patients with advanced cancer. The control group will receive a personalized web portal (called miOwnResources) with links to high quality cancer information, social support and interactive planning tools, and a feature to add their own links. All participants will sign informed consent forms, complete a pre-test survey and post-tests at tow and four months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin Carbone Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 30 - 60,
- Stage III or IV Cancer,
- Able and willing to use an internet computer to complete study activities.
Exclusion Criteria:
- Institutionalized, < 6 months prognosis,
- Cannot read or understand English,
- Unable or unwilling to use an internet computer to complete study activities.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: My Living Story
"My Living Story" elicits a dignity-enhancing life story via a telephone interview, and delivers the edited transcript on the patient's personal miLivingStory social network. miLivingStory also provides a direct link to miStory, a life review education website with links to high quality websites that provide cancer information, databases to "do your own research", social support, interactive planning tools, and a page to add their own weblinks. miLivingStory and miStory are both password protected. |
Components include: 1. Life Review Interview by phone (questions based on Chochinov, 2002 dignity enhancing interview); 2) Edited transcript is delivered in a word format on...; 3) miLivingStory, a personal social network, where participants can manage content, design and layer; invite and manage their fiends and family. 4) miStory, a life review education website and portal to websites for: cancer information, databases to "do your own research," social support, interactive planning tools, and a page to add their own weblinks. |
|
Active Comparator: My Own Resources
My Own Resources offers usual care access to high quality websites that provide cancer information, databases to "do your own research," social support, and interactive planning tools.
Participants will receive access to the website miOwnResources.
|
Components include: 1. Life Review Interview by phone (questions based on Chochinov, 2002 dignity enhancing interview); 2) Edited transcript is delivered in a word format on...; 3) miLivingStory, a personal social network, where participants can manage content, design and layer; invite and manage their fiends and family. 4) miStory, a life review education website and portal to websites for: cancer information, databases to "do your own research," social support, interactive planning tools, and a page to add their own weblinks.
miOwnResources is a personalized, password-protected web portal to high quality websites that provide cancer information, cancer research databases for "do your own research," social support, and interactive planning tools.
miOwnResources also has a page for participants to add their own weblinks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Existential Well-being (FACIT-Sp)
Time Frame: 0, 2 and 4 months
|
0, 2 and 4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Distress (POMS-SF)
Time Frame: 0, 2, and 4 months
|
0, 2, and 4 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Margaret (Meg) E Wise, PhD, University of Wisconsin, Madison
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-2009-1189 (Other Identifier: Institutional Review Board)
- R21CA129890-01A2 (U.S. NIH Grant/Contract)
- CC09310 (Other Identifier: University of Wisconsin Carbone Cancer Center)
- A568000 (Other Identifier: UW Madison)
- PHARM/SRC (Other Identifier: UW Madison)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metastatic Cancer
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedGIST Metastatic Cancer | Breast Metastatic Cancer | Kidney Metastatic Cancer | Colon Metastatic Cancer | Rectal Metastatic CancerFrance
-
Jiangsu Cancer Institute & HospitalRecruitingOvarian Cancer Metastatic | Ovarian Cancer Metastatic RecurrentChina
-
Albert Einstein College of MedicineTerminatedCancer | Solid Tumor | Metastatic Solid Tumor | Metastatic dMMR Solid CancerUnited States
-
Orion Biotechnology Polska Sp. z o.o.WithdrawnMetastatic Colorectal Cancer | Metastatic Cancer | Metastatic Breast Cancer | Metastatic Urothelial Carcinoma | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer
-
Oncolytics BiotechRecruitingmCRC | Ras-mutated Metastatic Colorectal Cancer | MSS Metastatic Colorectal CancerUnited States
-
Institut de Cancérologie de la LoireSaint-Louis Hospital, Paris, France; Gustave Roussy, Cancer Campus, Grand ParisWithdrawnMetastatic Colorectal Cancer | Metastatic Breast Cancer | Metastatic Head and Neck CancerFrance
-
Gottfried MayaUnknownMetastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Prostate Cancer | Metastatic Gastric Cancer | Metastatic Bladder CancerIsrael
-
Advaxis, Inc.TerminatedMetastatic Melanoma | Urothelial Carcinoma | Metastatic Non-Small Cell Lung Cancer | Head and Neck Cancer Metastatic | Colon Cancer MetastaticUnited States
-
Cota Inc.Blue Cross Blue Shield; NantHealth Inc.TerminatedPancreatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Melanoma | Metastatic Prostate Cancer | Metastatic Colon CancerUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedMetastatic Colorectal Cancer | Advanced Solid Tumors | Advanced or Metastatic Biliary CancerUnited States
Clinical Trials on My Living Story
-
VA Office of Research and DevelopmentCompletedDiabetes MellitusUnited States
-
Massachusetts General HospitalUniversity of IbadanRecruitingDepression | Hiv | Psychological DistressNigeria
-
Jennifer AccardoAmerican Academy of Sleep MedicineCompletedChild | Developmental Disabilities | Sleep Disorders | Polysomnography | Preparation for Medical ProcedureUnited States
-
Paris Translational Research Center for Organ TransplantationRecruiting
-
City University of New YorkNot yet recruitingIntersectional Stigma
-
Okan UniversityCompletedPain | Burns | Anxiety | FearTurkey
-
Universitätsklinikum Hamburg-EppendorfCompletedRole-expectancy on Patient Reported OutcomesGermany
-
University of California, RiversideRecruiting
-
The Royal Wolverhampton Hospitals NHS TrustCompletedDiabetes | Care DeliveryUnited Kingdom
-
University Hospital, GhentGeneral Hospital Groeninge; University Ghent; Algemeen Ziekenhuis Maria Middelares and other collaboratorsRecruitingCancer | Oncologic DiseasesBelgium